GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (FRA:NPAU) » Definitions » Cash Flow from Discontinued Operations

BetterLife Pharma (FRA:NPAU) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Jul. 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

BetterLife Pharma's cash flow from discontinued operations for the three months ended in Jul. 2024 was €0.00 Mil. It means BetterLife Pharma received €0.00 Mil from the sale of part of business quarterly. BetterLife Pharma's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Jul. 2024 was €0.00 Mil.

BetterLife Pharma Cash Flow from Discontinued Operations Historical Data

The historical data trend for BetterLife Pharma's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Cash Flow from Discontinued Operations Chart

BetterLife Pharma Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BetterLife Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BetterLife Pharma Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

BetterLife Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (FRA:NPAU) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
TSXV:XRTX XCNQ:TRYP XCNQ:CHGX TSXV:HEM XCNQ:DRUG TSXV:RKV TSXV:RP TSX:APLI XCNQ:MESC XCNQ:GLOW OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
BETRF:USA BETR:Canada
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
Website
https://www.abetterlifepharma.com
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma Headlines

No Headlines